SEARCH OUR PRODUCT CATALOG

C11ORF49-NUP98 Fusion FISH Probe

The C11ORF49-NUP98 Fusion FISH Probe is used to confirm a fusion of the C11ORF49 and NUP98 genes. The fusion of the C11ORF49 and NUP98 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
C11ORF49-NUP98-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
C11ORF49-NUP98-20-RERE 20 (40 μL) 200 μL
C11ORF49-NUP98-20-REOR 20 (40 μL) 200 μL
C11ORF49-NUP98-20-REGO 20 (40 μL) 200 μL
C11ORF49-NUP98-20-REGR 20 (40 μL) 200 μL
C11ORF49-NUP98-20-REAQ 20 (40 μL) 200 μL
C11ORF49-NUP98-20-ORRE 20 (40 μL) 200 μL
C11ORF49-NUP98-20-OROR 20 (40 μL) 200 μL
C11ORF49-NUP98-20-ORGO 20 (40 μL) 200 μL
C11ORF49-NUP98-20-ORAQ 20 (40 μL) 200 μL
C11ORF49-NUP98-20-GORE 20 (40 μL) 200 μL
C11ORF49-NUP98-20-GOOR 20 (40 μL) 200 μL
C11ORF49-NUP98-20-GOGO 20 (40 μL) 200 μL
C11ORF49-NUP98-20-GOGR 20 (40 μL) 200 μL
C11ORF49-NUP98-20-GOAQ 20 (40 μL) 200 μL
C11ORF49-NUP98-20-GRRE 20 (40 μL) 200 μL
C11ORF49-NUP98-20-GROR 20 (40 μL) 200 μL
C11ORF49-NUP98-20-GRGO 20 (40 μL) 200 μL
C11ORF49-NUP98-20-GRGR 20 (40 μL) 200 μL
C11ORF49-NUP98-20-GRAQ 20 (40 μL) 200 μL
C11ORF49-NUP98-20-AQRE 20 (40 μL) 200 μL
C11ORF49-NUP98-20-AQOR 20 (40 μL) 200 μL
C11ORF49-NUP98-20-AQGO 20 (40 μL) 200 μL
C11ORF49-NUP98-20-AQGR 20 (40 μL) 200 μL
C11ORF49-NUP98-20-AQAQ 20 (40 μL) 200 μL

NUP98 Gene Summary

Nuclear pore complexes (NPCs) regulate the transport of macromolecules between the nucleus and cytoplasm, and are composed of many polypeptide subunits, many of which belong to the nucleoporin family. This gene belongs to the nucleoporin gene family and encodes a 186 kDa precursor protein that undergoes autoproteolytic cleavage to generate a 98 kDa nucleoporin and 96 kDa nucleoporin. The 98 kDa nucleoporin contains a Gly-Leu-Phe-Gly (GLGF) repeat domain and participates in many cellular processes, including nuclear import, nuclear export, mitotic progression, and regulation of gene expression. The 96 kDa nucleoporin is a scaffold component of the NPC. Proteolytic cleavage is important for targeting of the proteins to the NPC. Translocations between this gene and many other partner genes have been observed in different leukemias. Rearrangements typically result in chimeras with the N-terminal GLGF domain of this gene to the C-terminus of the partner gene. Alternative splicing results in multiple transcript variants encoding different isoforms, at least two of which are proteolytically processed. Some variants lack the region that encodes the 96 kDa nucleoporin. [provided by RefSeq, Feb 2016]

Gene Name: Nucleoporin 98

Chromosome: CHR11: 3696239 -3819022

Locus: 11p15.4

C11orf49 Gene Summary

The Chromosome 11 Open Reading Frame 49 (C11orf49) gene is located on chr11 :46958250-47185931 at 11p11.2.

Gene Name: Chromosome 11 Open Reading Frame 49

Chromosome: CHR11: 46958250 -47185931

Locus: 11p11.2

Gene Diseases

The C11ORF49 NUP98 Fusion has been associated with the following diseases:

Disease Name
Prostate Adenocarcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Rapid detection of chromosomal translocation and precise breakpoint characterization in acute myeloid leukemia by nanopore long-read sequencing

Detection of chromosomal translocations has proven crucial for diagnosis and management of acute myeloid leukemia (AML), a cancer known to harbor several distinct gene rearrangements that correlate with disease subtype. In this study, an AML patient was genetically profiled using both conventional karyotyping and next generation sequencing techniques. FISH was also used to detect NUP98 translocations using Empire Genomics’ NUP98 break-apart probe.